Dalmau Serra J, Ferrer Lorente B, Modesto Alapont V, Guillén Domínguez M, Vázquez Gomis R, Corella Piquer D, Cabello Tomás M L, García Gómez A M
Unidad de Nutrición y Metabolopatías, Hospital Infantil La Fe, Valencia, Spain.
An Esp Pediatr. 2002 May;56(5):409-15.
Moderately increased plasma homocysteine (Hcy) in children has been associated with stroke and venous thrombosis and with a parental history of cardiovascular disease (CVD). Evaluation of Hcy concentrations during childhood and study of the factors determining its concentrations could play an important role in the primary prevention of CVD. Objective To detect cases of hyperhomocystinemia and to examine the association between Hcy levels and plasma folic acid levels and 677C T polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR).
The relationship between plasma Hcy levels, plasma folic acid levels, and the three genotypes of 677C T MTHFR polymorphism was investigated in 127 children (aged 2-18 years) and in 105 parents by multiple linear regression.
The median Hcy levels were 5.00 mol/l in the children and 8.00 mol/l in the parents. Plasma folic acid levels were normal in all of the patients. The prevalence of the three genotypes in the children was 32.3 % for the CC genotype, 42.5 % for the CT genotype and 15.7 % for the TT genotype. Hcy concentrations were significantly higher in children with the TT genotype (p 0.018). Multiple linear regression revealed a positive direct effect of age (b 0.029, p 0.002) and a negative effect of genotype TT (b 3.886, p 0.002) on Hcy concentration. Hcy concentration was inversely correlated with folic acid levels but this correlation did not reach statistical significance.
No cases of hyperhomocystinemia were found. To evaluate Hcy, age and plasma folic acid levels have to be taken into account in case there is a 677C T mutation. Hcy concentrations should be determined in older children with a family history of atherothrombosis and other risk factors for premature CVD.
儿童血浆同型半胱氨酸(Hcy)适度升高与中风、静脉血栓形成以及父母心血管疾病(CVD)病史有关。评估儿童期Hcy浓度以及研究决定其浓度的因素可能在CVD的一级预防中发挥重要作用。目的检测高同型半胱氨酸血症病例,并研究Hcy水平与血浆叶酸水平以及5,10-亚甲基四氢叶酸还原酶(MTHFR)677C→T多态性之间的关联。
通过多元线性回归研究了127名儿童(2至18岁)和105名父母的血浆Hcy水平、血浆叶酸水平以及MTHFR 677C→T多态性的三种基因型之间的关系。
儿童的Hcy水平中位数为5.00μmol/L,父母为8.00μmol/L。所有患者的血浆叶酸水平均正常。儿童中三种基因型的患病率分别为:CC基因型32.3%,CT基因型42.5%,TT基因型15.7%。TT基因型儿童的Hcy浓度显著更高(p = 0.018)。多元线性回归显示年龄对Hcy浓度有正向直接影响(b = 0.029,p = 0.002),TT基因型有负向影响(b = -3.886,p = 0.002)。Hcy浓度与叶酸水平呈负相关,但这种相关性未达到统计学意义。
未发现高同型半胱氨酸血症病例。在存在677C→T突变的情况下,评估Hcy时必须考虑年龄和血浆叶酸水平。对于有动脉粥样硬化血栓形成家族史以及其他过早发生CVD风险因素的大龄儿童,应测定Hcy浓度。